Gast ::
| Hauptseite > Publikationsdatenbank > Sulfite oxidase deficiency causes persulfidation loss and hydrogen sulfide release > print |
| Hauptseite > Publikationsdatenbank > Sulfite oxidase deficiency causes persulfidation loss and hydrogen sulfide release > print |
| 001 | 1048140 | ||
| 005 | 20251117202148.0 | ||
| 024 | 7 | _ | |a 10.1172/JCI181299 |2 doi |
| 024 | 7 | _ | |a 0021-9738 |2 ISSN |
| 024 | 7 | _ | |a 1558-8238 |2 ISSN |
| 024 | 7 | _ | |a 10.34734/FZJ-2025-04520 |2 datacite_doi |
| 037 | _ | _ | |a FZJ-2025-04520 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Fu, Chun-Yu |0 P:(DE-HGF)0 |b 0 |
| 245 | _ | _ | |a Sulfite oxidase deficiency causes persulfidation loss and hydrogen sulfide release |
| 260 | _ | _ | |a Ann Arbor, Mich. |c 2025 |b ASCJ |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1763392230_32605 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Sulfite oxidase (SOX) deficiency is a rare inborn error of cysteine metabolism resulting in severe neurological damage. In patients, sulfite accumulates to toxic levels, causing a rise in the downstream products S-sulfocysteine, which mediates excitotoxicity, and thiosulfate, a catabolic intermediate/product of hydrogen sulfide (H2S) metabolism. Here, we report a full-body knockout mouse model for SOX deficiency (SOXD) with a severely impaired phenotype. Among the urinary biomarkers, thiosulfate showed a 45-fold accumulation in SOXD mice, representing the major excreted S-metabolite. Consistently, we found increased plasma H2S, which was derived from sulfite-induced release from persulfides, as demonstrated in vitro and in vivo. Mass spectrometry analysis of total protein persulfidome identified a major loss of S-persulfidation in 20% of the proteome, affecting enzymes in amino acids, fatty acid metabolism, and cytosolic iron-sulfur cluster biogenesis. Urinary amino acid profiles indicated metabolic rewiring and mitochondrial dysfunction, thus identifying an altered H2S metabolism and persulfidation in SOXD. Finally, oxidized glutathione and glutathione trisulfide were able to scavenge sulfite in vitro and in vivo, extending the lifespan of SOXD mice and providing a mechanistic concept of sulfite scavenging for the treatment of this severe metabolic disorder of cysteine catabolism. |
| 536 | _ | _ | |a 5253 - Neuroimaging (POF4-525) |0 G:(DE-HGF)POF4-5253 |c POF4-525 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de |
| 700 | 1 | _ | |a Kohl, Joshua B. |0 P:(DE-HGF)0 |b 1 |
| 700 | 1 | _ | |a Liebsch, Filip |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a D’Andrea, Davide |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Ditrói, Tamás |0 P:(DE-HGF)0 |b 4 |
| 700 | 1 | _ | |a Ogata, Seiryo |0 P:(DE-HGF)0 |b 5 |
| 700 | 1 | _ | |a Neuser, Franziska |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Mai, Max |0 P:(DE-HGF)0 |b 7 |
| 700 | 1 | _ | |a Mellis, Anna T. |0 P:(DE-HGF)0 |b 8 |
| 700 | 1 | _ | |a Kouroussis, Emilia |0 P:(DE-HGF)0 |b 9 |
| 700 | 1 | _ | |a Morita, Masanobu |0 P:(DE-HGF)0 |b 10 |
| 700 | 1 | _ | |a Gehling, Titus |0 P:(DE-HGF)0 |b 11 |
| 700 | 1 | _ | |a Santamaria-Araujo, José Angel |0 P:(DE-HGF)0 |b 12 |
| 700 | 1 | _ | |a Yeo, Sin Yuin |0 P:(DE-HGF)0 |b 13 |
| 700 | 1 | _ | |a Endepols, Heike |0 P:(DE-Juel1)180330 |b 14 |u fzj |
| 700 | 1 | _ | |a Křížková, Michaela |0 P:(DE-HGF)0 |b 15 |
| 700 | 1 | _ | |a Kozich, Viktor |0 P:(DE-HGF)0 |b 16 |
| 700 | 1 | _ | |a Krueger, Marcus |0 P:(DE-HGF)0 |b 17 |
| 700 | 1 | _ | |a Hennermann, Julia B. |0 P:(DE-HGF)0 |b 18 |
| 700 | 1 | _ | |a Barayeu, Uladzimir |0 P:(DE-HGF)0 |b 19 |
| 700 | 1 | _ | |a Akaike, Takaaki |0 0000-0002-0623-1710 |b 20 |
| 700 | 1 | _ | |a Nagy, Peter |0 P:(DE-HGF)0 |b 21 |
| 700 | 1 | _ | |a Filipovic, Milos |0 P:(DE-HGF)0 |b 22 |
| 700 | 1 | _ | |a Schwarz, Guenter |0 P:(DE-HGF)0 |b 23 |e Corresponding author |
| 773 | _ | _ | |a 10.1172/JCI181299 |g Vol. 135, no. 21, p. e181299 |0 PERI:(DE-600)2018375-6 |n 21 |p e181299 |t The journal of clinical investigation |v 135 |y 2025 |x 0021-9738 |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/1048140/files/181299.1-20251029171855-covered-e0fd13ba177f913fd3156f593ead4cfd.pdf |y OpenAccess |
| 909 | C | O | |o oai:juser.fz-juelich.de:1048140 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 14 |6 P:(DE-Juel1)180330 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Natural, Artificial and Cognitive Information Processing |1 G:(DE-HGF)POF4-520 |0 G:(DE-HGF)POF4-525 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-500 |4 G:(DE-HGF)POF |v Decoding Brain Organization and Dysfunction |9 G:(DE-HGF)POF4-5253 |x 0 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2024-12-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2024-12-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2024-12-27 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b J CLIN INVEST : 2022 |d 2024-12-27 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J CLIN INVEST : 2022 |d 2024-12-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2024-02-16T10:37:49Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2024-02-16T10:37:49Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2024-12-27 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2024-12-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-27 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-27 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2024-12-27 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2024-12-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-27 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-27 |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-5-20090406 |k INM-5 |l Nuklearchemie |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-Juel1)INM-5-20090406 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|